FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * EBBELING ROBERT B   2. Issuer Name and Ticker or Trading Symbol HAEMONETICS CORP [HAE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Vice President, Operations (Last) (First) (Middle) 400 WOOD ROAD 3. Date of Earliest Transaction (Month/Day/Year) 02/13/2007 (Street) BRAINTREE, MA 02184 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/13/2007   M   2,300 A $ 17 26,160 D   Common Stock 02/13/2007   S   2,300 D $ 47.0252 23,860 D   Common Stock 02/13/2007   M   10,000 A $ 17 33,860 D   Common Stock 02/13/2007   S   10,000 D $ 47.014 23,860 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-Qualified Stock Option (right to buy)

$ 17

02/13/2007

M

2,300

02/13/2007(1)

04/18/2007

Common Stock

2,300

$ 47.0161

10,000

D

Non-Qualified Stock Option (right to buy)

$ 17

02/13/2007

M

10,000

02/13/2007(2)

04/18/2007

Common Stock

10,000

$ 47.0161

0

D

Non-Qualified Stock Option (right to buy)

$ 15.4063

(1)

04/01/2009

Common Stock

10,500

10,500

D

Non-Qualified Stock Option (right to buy)

$ 15.875

(3)

05/03/2009

Common Stock

18,904

18,904

D

Non-Qualified Stock Option (right to buy)

$ 22.9063

(4)

05/01/2010

Common Stock

19,927

19,927

D

Non-Qualified Stock Option (right to buy)

$ 26.105

(1)

05/05/2014

Common Stock

15,000

15,000

D

Non-Qualified Stock Option (right to buy)

$ 31.66

(1)

04/29/2012

Common Stock

22,000

22,000

D

Non-Qualified Stock Option (right to buy)

$ 33.15

(1)

04/30/2011

Common Stock

10,000

10,000

D

Non-Qualified Stock Option (right to buy)

$ 41.15

(1)

07/27/2012

Common Stock

19,000

19,000

D

Non-Qualified Stock Option (right to buy)

$ 52.76

05/05/2007(1)

05/05/2013

Common Stock

16,644

16,644

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
EBBELING ROBERT B 400 WOOD ROAD BRAINTREE, MA 02184			Vice President, Operations

Signatures

By: Susan Hanlon For: Robert B Ebbeling		02/15/2007
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
(2)	Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the fifth anniversary of the date of grant. Vesting is accelerated when the fair market value of Haemonetics share price exceeds certain target levels for ten consecutive days.
(3)	Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 50 percent beginning on the first anniversary of the date of grant.
(4)	Grant to reporting person of right to buy shares of common stock, exercisable 50% on 3/31/2001 and 50% on 3/31/2002.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.